Dr. Reddy's Laboratories
249 hedge funds and large institutions have $1.67B invested in Dr. Reddy's Laboratories in 2026 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 103 increasing their positions, 64 reducing their positions, and 26 closing their positions.
62% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 26
61% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 64
11% more capital invested
Capital invested by funds: $1.5B → $1.67B (+$170M)
6% more funds holding
Funds holding: 236 → 249 (+13)
1.67% more ownership
Funds ownership: 12.76% → 14.43% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
99% less call options, than puts
Call options by funds: $6K | Put options by funds: $569K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$56M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$39.8M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$35M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$29.9M |
| 5 |
BlackRock
New York
|
+$17.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$15.3M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$13.5M |
| 3 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$9.51M |
| 4 |
Jane Street
New York
|
-$7.99M |
| 5 |
Renaissance Technologies
New York
|
-$5.5M |
RDY Hedge Fund Activity: Q1 2026 in Review
249 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2026, worth a combined $1.67B — up 11% from $1.5B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new RDY positions and 26 closed out — a net gain of 16 holders — while 103 added to existing stakes and 64 trimmed.
The largest buyer was Robeco Institutional Asset Management, adding an estimated $56M. The largest seller was JP Morgan Chase, cutting an estimated $15.3M.
- 249 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2026, up from 236 in Q4 2025.
- Funds reported $1.67B of Dr. Reddy's Laboratories stock for Q1 2026, up 11% quarter-over-quarter.
- 42 funds opened new Dr. Reddy's Laboratories positions in Q1 2026 and 26 closed out, a net change of +16 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2026 was Robeco Institutional Asset Management, an estimated $56M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2026 was JP Morgan Chase, an estimated $15.3M sold.
Based on aggregated 13F filings for Q1 2026.